AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
INTRACELLULAR TRAFFICKING OF FACTOR-VIII TO VON-WILLEBRAND-FACTOR STORAGE GRANULES
Authors: ROSENBERG JB FOSTER PA KAUFMAN RJ VOKAC EA MOUSSALLI M KRONER PA MONTGOMERY RR
Citation: Jb. Rosenberg et al., INTRACELLULAR TRAFFICKING OF FACTOR-VIII TO VON-WILLEBRAND-FACTOR STORAGE GRANULES, The Journal of clinical investigation, 101(3), 1998, pp. 613-624
MULTICENTER EVALUATION OF PCR METHODS FOR THE DETECTION OF FACTOR-V-LEIDEN (R506Q) GENOTYPES
Authors: LUTZ CT FOSTER PA NOLL WW VOELKERDING KV PRESS RD MCGLENNEN RC KIRSCHBAUM NE
Citation: Ct. Lutz et al., MULTICENTER EVALUATION OF PCR METHODS FOR THE DETECTION OF FACTOR-V-LEIDEN (R506Q) GENOTYPES, Clinical chemistry, 44(6), 1998, pp. 1356-1358
COLOCALIZATION AND INTRACELLULAR INTERACTION OF FVIII AND VWF IN STORAGE GRANULES
Authors: ROSENBERG JB FOSTER PA VOKAC EA KAUFMAN RJ KRONER PA MONTGOMERY RR
Citation: Jb. Rosenberg et al., COLOCALIZATION AND INTRACELLULAR INTERACTION OF FVIII AND VWF IN STORAGE GRANULES, Thrombosis and haemostasis, 1997, pp. 1531-1531
ADRENOCORTICOTROPIC HORMONE INFUSION AS A NOVEL TREATMENT FOR POSTDURAL PUNCTURE HEADACHE
Authors: KSHATRI AM FOSTER PA
Citation: Am. Kshatri et Pa. Foster, ADRENOCORTICOTROPIC HORMONE INFUSION AS A NOVEL TREATMENT FOR POSTDURAL PUNCTURE HEADACHE, Regional anesthesia, 22(5), 1997, pp. 432-434
PHENOTYPIC CORRECTION OF ACTIVATED PROTEIN-C RESISTANCE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: FOSTER PA VARMA RR
Citation: Pa. Foster et Rr. Varma, PHENOTYPIC CORRECTION OF ACTIVATED PROTEIN-C RESISTANCE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION, Blood coagulation & fibrinolysis, 7(1), 1996, pp. 65-68
THE PERIPHERAL PULSE-WAVE - INFORMATION OVERLOOKED
Authors: MURRAY WB FOSTER PA
Citation: Wb. Murray et Pa. Foster, THE PERIPHERAL PULSE-WAVE - INFORMATION OVERLOOKED, Journal of clinical monitoring, 12(5), 1996, pp. 365-377
IMPROVED METHOD FOR FACTOR-V LEIDEN TYPING BY PCR-SSP
Authors: BELLISSIMO DB KIRSCHBAUM NE FOSTER PA
Citation: Db. Bellissimo et al., IMPROVED METHOD FOR FACTOR-V LEIDEN TYPING BY PCR-SSP, Thrombosis and haemostasis, 75(3), 1996, pp. 520-520
ANTISOCIAL-BEHAVIOR IN SCHOOL - STRATEGIES AND BEST PRACTICES - WALKER,HM, COLVIN,G, RAMSEY,E
Authors: FOSTER PA LANDAU S
Citation: Pa. Foster et S. Landau, ANTISOCIAL-BEHAVIOR IN SCHOOL - STRATEGIES AND BEST PRACTICES - WALKER,HM, COLVIN,G, RAMSEY,E, Contemporary psychology, 41(8), 1996, pp. 804-806
COLOCALIZATION AND INTRACELLULAR INTERACTION OF FVII AND VWF IN STORAGE GRANULES
Authors: ROSENBERG JB FOSTER PA VOKAC EA KAUFMAN RJ KRONER PA MONTGOMERY RR
Citation: Jb. Rosenberg et al., COLOCALIZATION AND INTRACELLULAR INTERACTION OF FVII AND VWF IN STORAGE GRANULES, Blood, 88(10), 1996, pp. 2029-2029
THE DEFECTIVE INTERACTION BETWEEN VON-WILLEBRAND-FACTOR AND FACTOR-VIII IN A PATIENT WITH TYPE-1 VON-WILLEBRAND DISEASE IS CAUSED BY SUBSTITUTION OF ARG19 AND HIS54 IN MATURE VON-WILLEBRAND-FACTOR
Authors: KRONER PA FOSTER PA FAHS SA MONTGOMERY RR
Citation: Pa. Kroner et al., THE DEFECTIVE INTERACTION BETWEEN VON-WILLEBRAND-FACTOR AND FACTOR-VIII IN A PATIENT WITH TYPE-1 VON-WILLEBRAND DISEASE IS CAUSED BY SUBSTITUTION OF ARG19 AND HIS54 IN MATURE VON-WILLEBRAND-FACTOR, Blood, 87(3), 1996, pp. 1013-1021
A PERSPECTIVE ON THE USE OF FVIII CONCENTRATES AND CRYOPRECIPITATE PROPHYLACTICALLY IN SURGERY OR THERAPEUTICALLY IN SEVERE BLEEDS IN PATIENTS WITH VON-WILLEBRAND DISEASE UNRESPONSIVE TO DDAVP - RESULTS OF AN INTERNATIONAL SURVEY
Authors: FOSTER PA
Citation: Pa. Foster, A PERSPECTIVE ON THE USE OF FVIII CONCENTRATES AND CRYOPRECIPITATE PROPHYLACTICALLY IN SURGERY OR THERAPEUTICALLY IN SEVERE BLEEDS IN PATIENTS WITH VON-WILLEBRAND DISEASE UNRESPONSIVE TO DDAVP - RESULTS OF AN INTERNATIONAL SURVEY, Thrombosis and haemostasis, 74(5), 1995, pp. 1370-1378
THE POLYMERASE CHAIN-REACTION WITH SEQUENCE-SPECIFIC PRIMERS FOR THE DETECTION OF THE FACTOR-V MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-CRESISTANCE
Authors: KIRSCHBAUM NE FOSTER PA
Citation: Ne. Kirschbaum et Pa. Foster, THE POLYMERASE CHAIN-REACTION WITH SEQUENCE-SPECIFIC PRIMERS FOR THE DETECTION OF THE FACTOR-V MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-CRESISTANCE, Thrombosis and haemostasis, 74(3), 1995, pp. 874-878
THE REPRODUCTIVE HEALTH OF WOMEN WITH VON-WILLEBRAND DISEASE UNRESPONSIVE TO DDAVP - RESULTS OF AN INTERNATIONAL SURVEY
Authors: FOSTER PA
Citation: Pa. Foster, THE REPRODUCTIVE HEALTH OF WOMEN WITH VON-WILLEBRAND DISEASE UNRESPONSIVE TO DDAVP - RESULTS OF AN INTERNATIONAL SURVEY, Thrombosis and haemostasis, 74(2), 1995, pp. 784-790
LONGITUDINAL CHANGES IN ANTI-FACTOR-VIII IGG SUBCLASS COMPOSITION IN HEMOPHILIC PATIENTS WITH INHIBITORS
Authors: GILL JC STEPHANY K FOSTER PA
Citation: Jc. Gill et al., LONGITUDINAL CHANGES IN ANTI-FACTOR-VIII IGG SUBCLASS COMPOSITION IN HEMOPHILIC PATIENTS WITH INHIBITORS, Thrombosis and haemostasis, 73(6), 1995, pp. 1028-1028
THE VWAGII VWF - AG RATIO IS ABNORMALLY LOW IN INDIVIDUALS WITH VWD TYPE-IIC MIAMI SUGGESTING AN ABNORMALITY IN VWF PROPOLYPEPTIDE/
Authors: FOSTER PA LEDFORD MR VOKAC E MONTGOMERY RR
Citation: Pa. Foster et al., THE VWAGII VWF - AG RATIO IS ABNORMALLY LOW IN INDIVIDUALS WITH VWD TYPE-IIC MIAMI SUGGESTING AN ABNORMALITY IN VWF PROPOLYPEPTIDE/, Thrombosis and haemostasis, 73(6), 1995, pp. 1168-1168
A ONE-STEP PCR ASSAY FOR DETECTION OF THE FACTOR-V LEIDEN MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE
Authors: KIRSCHBAUM NE FOSTER PA
Citation: Ne. Kirschbaum et Pa. Foster, A ONE-STEP PCR ASSAY FOR DETECTION OF THE FACTOR-V LEIDEN MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE, Thrombosis and haemostasis, 73(6), 1995, pp. 1363-1363
ACTIVATED PROTEIN-C RESISTANCE IN A NEONATE WITH VENOUS THROMBOSIS
Authors: KODISH E POTTER C KIRSCHBAUM NE FOSTER PA
Citation: E. Kodish et al., ACTIVATED PROTEIN-C RESISTANCE IN A NEONATE WITH VENOUS THROMBOSIS, The Journal of pediatrics, 127(4), 1995, pp. 645-648
EARLY ANTI-FACTOR-VIII IGG SUBCLASS COMPOSITION MAY DIFFERENTIATE TRANSIENT FROM PERSISTENT INHIBITORS IN HEMOPHILIC PATIENTS
Authors: GILL JC STEPHANY K NEWTONNASH D FOSTER PA
Citation: Jc. Gill et al., EARLY ANTI-FACTOR-VIII IGG SUBCLASS COMPOSITION MAY DIFFERENTIATE TRANSIENT FROM PERSISTENT INHIBITORS IN HEMOPHILIC PATIENTS, Blood, 86(10), 1995, pp. 750-750
THE VON-WILLEBRAND-FACTOR PROPOLYPEPTIDE, VON-WILLEBRAND ANTIGEN-II (VWAGII), DISTINGUISHES ACQUIRED VON-WILLEBRAND SYNDROME (AVWS) DUE TO DECREASED SYNTHESIS OF VON-WILLEBRAND-FACTOR (VWF) FROM AVWS DUE TO INCREASED CLEARANCE OF VWF
Authors: SCOTT JP VOKAC EA SCHROEDER T FOSTER PA GILL JC MONTGOMERY PR
Citation: Jp. Scott et al., THE VON-WILLEBRAND-FACTOR PROPOLYPEPTIDE, VON-WILLEBRAND ANTIGEN-II (VWAGII), DISTINGUISHES ACQUIRED VON-WILLEBRAND SYNDROME (AVWS) DUE TO DECREASED SYNTHESIS OF VON-WILLEBRAND-FACTOR (VWF) FROM AVWS DUE TO INCREASED CLEARANCE OF VWF, Blood, 86(10), 1995, pp. 773-773
A POINT MUTATION IN THE D1 DOMAIN OF VON-WILLEBRAND-FACTOR RESULTS INDEFECTIVE COLLAGEN AND FACTOR-VIII BINDING BUT NOT PLATELET GBIB BINDING OR RELEASE FROM ATT-20 CELLS
Authors: ROSENBERG JB KRONER PA SCOTT JP GILL JC FOSTER PA KAWAI Y ABEL M VOKAC EA FAHS S MONTGOMERY RR
Citation: Jb. Rosenberg et al., A POINT MUTATION IN THE D1 DOMAIN OF VON-WILLEBRAND-FACTOR RESULTS INDEFECTIVE COLLAGEN AND FACTOR-VIII BINDING BUT NOT PLATELET GBIB BINDING OR RELEASE FROM ATT-20 CELLS, Blood, 86(10), 1995, pp. 1781-1781
APPARENT IGG ANTI-FACTOR-VIII ANTIBODIES IN NORMAL INDIVIDUALS ARE SPECIFIC FOR ABO BLOOD-GROUP SUBSTANCES
Authors: GILL JC STEPHANY K NEWTONNASH D FOSTER PA
Citation: Jc. Gill et al., APPARENT IGG ANTI-FACTOR-VIII ANTIBODIES IN NORMAL INDIVIDUALS ARE SPECIFIC FOR ABO BLOOD-GROUP SUBSTANCES, Blood, 86(10), 1995, pp. 2432-2432
ABERRANT MITOGEN-STIMULATED CYTOKINE PRODUCTION PROFILES IN PATIENTS WITH HEMOPHILIA-A (WITH OR WITHOUT FACTOR-VIII INHIBITORS) TREATED WITH HIGH-PURITY FACTOR-VIII CONCENTRATE
Authors: NEWTONNASH DK TOLLERUD D GUEVARRA L FOSTER PA GILL JC
Citation: Dk. Newtonnash et al., ABERRANT MITOGEN-STIMULATED CYTOKINE PRODUCTION PROFILES IN PATIENTS WITH HEMOPHILIA-A (WITH OR WITHOUT FACTOR-VIII INHIBITORS) TREATED WITH HIGH-PURITY FACTOR-VIII CONCENTRATE, Blood, 86(10), 1995, pp. 3518-3518
CRITICAL ISSUES RELATING STANDARDS FOR TECHNOLOGY TO PATIENT SAFETY
Authors: CALKINS JM ARNETT DW CARSTENSEN P CONDURSO JA FOSTER PA GERWER A GOOD M MOSS E REAM AK SPRAKER TE
Citation: Jm. Calkins et al., CRITICAL ISSUES RELATING STANDARDS FOR TECHNOLOGY TO PATIENT SAFETY, Journal of clinical monitoring, 10(5), 1994, pp. 296-303
MONOPHOSPHORYL LIPID A PROTECTS AGAINST ENDOTOXIC-SHOCK VIA INHIBITING NEUTROPHIL INFILTRATION AND PREVENTING DISSEMINATED INTRAVASCULAR COAGULATION
Authors: YAO ZH FOSTER PA GROSS GJ
Citation: Zh. Yao et al., MONOPHOSPHORYL LIPID A PROTECTS AGAINST ENDOTOXIC-SHOCK VIA INHIBITING NEUTROPHIL INFILTRATION AND PREVENTING DISSEMINATED INTRAVASCULAR COAGULATION, Circulatory shock, 43(3), 1994, pp. 107-114
THE BEHAVIOR OF IGE AND IGG4 SPECIFIC ANTI-FACTOR-VIII ANTIBODIES DURING IMMUNE TOLERANCE INDUCTION
Authors: GILL JC STEPHANY K KELLY K HARPER JL EVANS JP NEWTONNASH D FOSTER PA
Citation: Jc. Gill et al., THE BEHAVIOR OF IGE AND IGG4 SPECIFIC ANTI-FACTOR-VIII ANTIBODIES DURING IMMUNE TOLERANCE INDUCTION, Blood, 84(10), 1994, pp. 10000464-10000464
Risultati: 1-25 | 26-34